SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009722
Filing Date
2022-05-12
Accepted
2022-05-12 16:34:42
Documents
86
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sabs-20220331.htm   iXBRL 10-Q 2237641
2 EX-10.3 sabs-ex10_3.htm EX-10.3 146074
3 EX-31.1 sabs-ex31_1.htm EX-31.1 29870
4 EX-31.2 sabs-ex31_2.htm EX-31.2 29873
5 EX-32.1 sabs-ex32_1.htm EX-32.1 12882
6 EX-32.2 sabs-ex32_2.htm EX-32.2 13315
7 EX-99.1 sabs-ex99_1.htm EX-99.1 30205
8 GRAPHIC img1871078_0.jpg GRAPHIC 10481
  Complete submission text file 0000950170-22-009722.txt   9732867

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sabs-20220331_cal.xml EX-101.CAL 68143
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sabs-20220331.xsd EX-101.SCH 72513
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sabs-20220331_def.xml EX-101.DEF 305572
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sabs-20220331_lab.xml EX-101.LAB 556575
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sabs-20220331_pre.xml EX-101.PRE 451530
80 EXTRACTED XBRL INSTANCE DOCUMENT sabs-20220331_htm.xml XML 1686034
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39871 | Film No.: 22918442
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences